University of Lahore

uol.edu.pk

Total trials

183

Active

36

Phase 3

1

Total enrollment

13,791

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Stroke21
  • Neck Pain6
  • Adhesive Capsulitis5
  • Cerebral Palsy (CP)4
  • Hemiplegia4
  • Knee Osteoarthritis4
  • Cervical Radiculopathy4
  • Parkinson Disease4

Frequently asked questions about University of Lahore

How many clinical trials does University of Lahore have on ClinicalTrials.gov?
University of Lahore is listed as the lead sponsor on 183 clinical trials in ClinicalTrials.gov, 36 of which are currently active (recruiting, enrolling, or ongoing).
How many of University of Lahore's trials are in Phase 3?
1 of University of Lahore's trials are in Phase 3.
What therapeutic areas does University of Lahore focus on?
University of Lahore's most-studied conditions on ClinicalTrials.gov are Stroke, Neck Pain, Adhesive Capsulitis, Cerebral Palsy (CP), Hemiplegia.